Department of Clinical Oncology, Health Authority, Hong Kong, China.
Expert Rev Proteomics. 2014 Apr;11(2):131-3. doi: 10.1586/14789450.2014.899908.
This special focus issue of Expert Review of Proteomics invites key opinion leaders to report their recent findings and views on the important topic of translating potential proteomic biomarkers to clinically useful, regulator-approved biomarkers: a challenging journey. The issue also highlights the difficulties associated with and the way forward in the discovery of proteomic cancer biomarkers for clinical applications, as well as presenting recent original research in the field.
本期《蛋白质组学专家评论》特刊邀请了主要意见领袖，就将潜在的蛋白质组生物标志物转化为临床有用的、监管机构批准的生物标志物这一重要主题报告他们的最新发现和观点：这是一段充满挑战的旅程。本特刊还重点介绍了在发现用于临床应用的蛋白质组癌症生物标志物方面所面临的困难和前进的方向，并展示了该领域的最新原创研究。
